Skip to content

Guduchi Ghanavati as a prophylactic measure among population at high risk to SARS-CoV-2 exposure

A prospective non-randomised open label controlled interventional study on the effect of Guduchi Ghanavati as a prophylactic measure among population at high risk to SARS-CoV-2 exposure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025525
Enrollment
20000
Registered
2020-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Guduchi Ghanavati: 2 Pills of 250mg each Orally twice a day with water For 28 days Control Intervention1: No treatment in control group: As this is prophylaxis study no treatment arm

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects at high risk of exposure to COVID 19 infection such as Health care workers involved in treatment of COVID19 cases Frontline workers of city where COVID 19 cases detected Family members of COVID19 cases or direct contact People in quarantine People in containment zones Subjects who are ready to provide written or digital informed consent and who are willing to participate

Exclusion criteria

Exclusion criteria: Pregnant and Lactating female COVID 19 positive cases Known cases of uncontrolled Diabetes and Hypertension or any other systemic uncontrolled conditions Having immune compromised status like HIV Hepatitis Tuberculosis Cancer etc Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening Subjects taking Steroid treatment and or any kind of immunosuppressive therapy

Design outcomes

Primary

MeasureTime frame
Incidence rate of COVID 19 infectionTimepoint: 0 14 28 days

Secondary

MeasureTime frame
Changes in Immune Status QuestionnaireTimepoint: 0 14 and 28 days;Changes in WHO QOL BREFTimepoint: 0 14 and 28 days

Countries

India

Contacts

Public ContactKalpesh Panara

Institute for Post Graduate Teaching and Research in Ayurveda

kbpanara@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026